In this episode of The A100 Podcast, host Colleen Gallagher speaks with David Jackson, MBA, CAE, Executive Officer of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dave shares ASPET’s journey in preparing for the open access mandates coming in 2025 and offers actionable insights for associations navigating similar changes.
Key Highlights:
Strategic Open Access Transitions: Dave explains ASPET’s proactive approach to open access, including the launch of its new journal, ASPET Discovery, and the strategic publishing partnership with Elsevier.
Supporting Authors: Learn how ASPET is adapting its publishing model to increase accessibility and provide more options for authors, especially those from under-resourced institutions.
Future Trends: Explore Dave’s vision for the future of scientific publishing, including innovations in peer review, intellectual property considerations and the role of AI.
Join us as Dave Jackson provides a roadmap for associations preparing for the future of scholarly publishing.
Stay Connected:
Subscribe to The Association 100 podcast on Spotify, Apple Podcasts or YouTube Podcasts to ensure you never miss an episode.
Follow us on LinkedIn at The Association 100 and OnWrd & UpWrd for the latest in association trends and strategies.
Tune in for more episodes packed with expert insights to help your association thrive in a changing landscape!
